Intrahepatic Cholangiocarcinoma  >>  Koselugo (selumetinib) 
Welcome,         Profile    Billing    Logout  

0 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Koselugo (selumetinib) / Merck (MSD), AstraZeneca
No trials found

Download Options